ARCHIVES

OMB Orders NCI to Cut 12 Percent Until Final budget Is Approved; Grants Being Renegotiated

This article is from The Cancer Letter archive.

Vol. 07 No. 49 | December 4, 1981

Download PDF Visit The Full Archive

Related Articles

DCE Board Okays New Melanoma Study, Other Concepts

November 11, 1988

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

December 5, 2014

Cancer Prevention Grants Awarded To Five States, DC

June 30, 1989

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

Immune Systems Don’t Stop, Causing Fatigue For Survivors

May 26, 2006

Cancer Mortality Increase Of 5.2% Now 28% Or Less

January 30, 1976